These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 9439917)

  • 1. Clinical aspects and treatment of juvenile Graves' disease.
    Perrild H; Lavard L; Brock-Jacobsen B
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 4():55-7. PubMed ID: 9439917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of MHC and Gm in liability to autoimmune thyroid disease.
    Nagataki S
    Mol Biol Med; 1986 Feb; 3(1):73-84. PubMed ID: 3007922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graves' disease in children and adolescents: response to long-term treatment.
    Barrio R; López-Capapé M; Martinez-Badás I; Carrillo A; Moreno JC; Alonso M
    Acta Paediatr; 2005 Nov; 94(11):1583-9. PubMed ID: 16303698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of outcome in Graves' disease after carbimazole treatment.
    Weetman AP; Ratanachaiyavong S; Middleton GW; Love W; John R; Owen GM; Darke C; Lazarus JH; Hall R; McGregor AM
    Q J Med; 1986 Apr; 59(228):409-19. PubMed ID: 2875484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment outcome of Graves' disease in Thai children.
    Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
    J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of HLA antigens in the manifestation and course of Graves' disease.
    Stenszky V; Kozma L; Balazś C; Bear JC; Farid NR
    Mol Biol Med; 1986 Feb; 3(1):53-62. PubMed ID: 3485758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Graves' disease with the block-replace regimen of antithyroid drugs: the effect of treatment duration and immunogenetic susceptibility on relapse.
    Weetman AP; Pickerill AP; Watson P; Chatterjee VK; Edwards OM
    Q J Med; 1994 Jun; 87(6):337-41. PubMed ID: 7913766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DR associations with Graves' disease in eastern Hungary.
    Stenszky V; Kozma L; Balazs C; Farid NR
    Clin Invest Med; 1983; 6(3):181-4. PubMed ID: 6580983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Two cases of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) associated with Graves' disease].
    Kumazawa K; Sobue G; Okamoto H; Yuasa K; Mitsuma T
    Rinsho Shinkeigaku; 1991 Jul; 31(7):768-71. PubMed ID: 1786665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evolution of diagnostic and therapeutic criteria in Graves' disease in Spain. Comparison of the results of 2 surveys in 1987 and 1995].
    Escobar Jiménez F; Luna López V; Fernández Soto ML; Quezada Charneco M; Glinoer D
    Med Clin (Barc); 1998 Sep; 111(6):205-10. PubMed ID: 9789225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
    Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
    Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperthyroidism in childhood].
    Lombardo G; De Luca F; Trimarchi F; Bianchi C
    Pediatr Med Chir; 1983; 5(6):485-92. PubMed ID: 6085155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of management of Graves' disease in District General Hospital: achievement of consensus guidelines.
    Dasgupta S; Savage MW
    Int J Clin Pract; 2005 Sep; 59(9):1097-100. PubMed ID: 16115188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic evaluation of Graves' ophthalmopathy.
    Bahn RS; Garrity JA; Bartley GB; Gorman CA
    Endocrinol Metab Clin North Am; 1988 Sep; 17(3):527-45. PubMed ID: 3065079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the 2nd generation radio-receptional assay for anti-TSH receptor antibodies (TRAb) in autoimmune thyroid diseases. Comparison with 1st generation and anti-thyroperoxidase antibodies (AbTPO).
    Giovanella L; Ceriani L; Garancini S
    Q J Nucl Med; 2001 Mar; 45(1):115-9. PubMed ID: 11456370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid cancer yield in patients with Graves' disease.
    Stocker DJ; Burch HB
    Minerva Endocrinol; 2003 Sep; 28(3):205-12. PubMed ID: 14605602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting the likelihood of remission in children with Graves' disease: a prospective, multicenter study.
    Glaser NS; Styne DM;
    Pediatrics; 2008 Mar; 121(3):e481-8. PubMed ID: 18267979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre.
    Jansson R; Karlsson A; Forsum U
    Clin Exp Immunol; 1984 Nov; 58(2):264-72. PubMed ID: 6238731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical aspects of hyperthyroidism in areas of different supplies of iodine. Results of a European prospective study].
    Reinwein D; Benker G; König MP; Pinchera A; Schatz H; Schleusener H
    Schweiz Med Wochenschr; 1987 Aug; 117(34):1245-55. PubMed ID: 3672070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
    Wallaschofski H; Kuwert T; Lohmann T
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.